Hikma Pharmaceuticals Plc Holding(s) in Company (2317F)
November 10 2015 - 9:43AM
UK Regulatory
TIDMHIK
RNS Number : 2317F
Hikma Pharmaceuticals Plc
10 November 2015
Notification of major interests in shares
LONDON, 10 November 2015 - Hikma Pharmaceuticals PLC ("Hikma")
(LSE: HIK) (DIFX: HIK), the fast growing multinational
pharmaceuticals group, announces as follows:
1 Identity of the issuer or the underlying Hikma Pharmaceuticals PLC
issuer of existing shares to which the
voting rights are attached
----------------------------------------- --------------------------
2 Reason for the notification
--------------------------------------------------------- ----
An acquisition or disposal of voting rights Yes
--------------------------------------------------------- ----
An acquisition or disposal of financial instruments No
which may result in the acquisition of shares already
issues to which voting rights are attached
--------------------------------------------------------- ----
An event changing the breakdown of voting rights No
--------------------------------------------------------- ----
Other (please specify): Compliance with the Transparency No
Directive
--------------------------------------------------------- ----
3 Full name of the person subject to the FMR LLC
notification obligation
----- --------------------------------------------------------------- -------------------------------------
4 Full name of shareholders See Section 9
----- --------------------------------------------------------------- -------------------------------------
5 Date of the Transaction (and date on 5(th) November 2015
which the threshold crossed is reached
differently)
----- --------------------------------------------------------------- -------------------------------------
6 Date on which the issuer notified 6(th) November 2015
----- --------------------------------------------------------------- -------------------------------------
7 Threshold that is crossed 5%
----- --------------------------------------------------------------- -------------------------------------
8 Notified details See A, B & C below
----- --------------------------------------------------------------- -------------------------------------
A. Voting rights attached to shares
-------------------------------------------------------------------------------------------------------------
Class type Situation previous Resulting situation after the triggering
of shares to the triggering transaction
(if possible transaction
using the
ISIN code)
---------------- ------------------------ -----------------------------------------------------------------
Number Number Number of shares Number of voting % of voting
of shares of voting rights rights
rights
----- --------- ----------- ----------- ------------------- --------------------- ---------------------
Direct Indirect Direct Indirect Direct Indirect
----- --------- ----------- ----------- ------- ---------- --------- ---------- ------- ------------
Ordinary
Shares (0.10
GBP)
GB00B0LCW083 9,936,267 9,936,267 9,973,414 9,973,414 5.00%
---------------- ----------- ----------- ------- ---------- --------- ---------- ------- ------------
B. Qualifying Financial instruments
----------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/Conversion Number of voting % of voting rights
instrument Date Period/Date rights that may
be acquired if
the instrument
if exercised/converted
------------------ ----------- -------------------- ------------------------ -------------------
- - - - -
------------------ ----------- -------------------- ------------------------ -------------------
C: Financial Instruments with similar economic effect to Qualifying
Financial Instruments
------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/Conversion Number of voting % of voting rights
financial Price Date Period/Date rights instrument
instrument refers to
------------ --------- ----------- -------------------- ------------------- ---------------------
Nominal Delta
------------ --------- ----------- -------------------- ------------------- ----------- --------
- - - - - - -
------------ --------- ----------- -------------------- ------------------- ----------- --------
Total A+B+C
---------------------------------------------
Number of Voting rights % of voting rights
------------------------ -------------------
9,973,414 5.00
------------------------ -------------------
9 Chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held, if applicable
---------------------------------------------------------------------------------------------
Custodian Day to Day IM Total
BANK OF NEW YORK BRUSSELS (C) PGALLC-PYRAMIS GLOBAL ADVISORS, LLC 6,040
BANK OF NEW YORK MELLON PGALLC-PYRAMIS GLOBAL ADVISORS, LLC 116,750
PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS
BNP PARIBAS SEC SVCS LONDON TRUST COMPANY 47,071
BROWN BROS HARRIMN LTD LUX (C) FMRC-FMR CO., INC 486
BROWN BROTHERS HARRIMAN AND CO FMRC-FMR CO., INC 65,914
FMRIMUK-FMR INVESTMENT MANAGEMENT (UK) LIMITED 44,975
PGALLC-PYRAMIS GLOBAL ADVISORS, LLC 55,245
PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS TRUST COMPANY 537,558
CIBC MELLON TRUST (C) PGALLC-PYRAMIS GLOBAL ADVISORS, LLC 13,333
CITIBANK NA, HONG KONG BR (S) PGALLC-PYRAMIS GLOBAL ADVISORS, LLC 16,382
JP MORGAN, BOURNEMOUTH (C) PGALLC-PYRAMIS GLOBAL ADVISORS, LLC 9,809
PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS TRUST COMPANY 113,142
JPMORGAN CHASE BANK FMRC-FMR CO., INC 4,089,565
FMRIMUK-FMR INVESTMENT MANAGEMENT (UK) LIMITED 151,087
PGALLC-PYRAMIS GLOBAL ADVISORS, LLC 34,638
PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS TRUST COMPANY 58,643
MELLON BANK NA (C) PGALLC-PYRAMIS GLOBAL ADVISORS, LLC 259,991
PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS TRUST COMPANY 72,600
PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS
NATIONAL BANK TRUST (C) TRUST COMPANY 14,829
NOMURA TRUST AND BANKING (C) PGALLC-PYRAMIS GLOBAL ADVISORS, LLC 553
NORTHERN TRUST CO (C) FMRC-FMR CO., INC 200,615
FMRIMUK-FMR INVESTMENT MANAGEMENT (UK) LIMITED 2,598,333
PGALLC-PYRAMIS GLOBAL ADVISORS, LLC 36,157
PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS TRUST COMPANY 272,510
STATE STREET BANK AND TR CO FMRC-FMR CO., INC 303,042
PGALLC-PYRAMIS GLOBAL ADVISORS, LLC 472,652
PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS TRUST COMPANY 381,494
Grand Total 9,973,414
---------------------------------------------------------------------------- ----------
---------------------------------------------------------------------------------------------
Proxy Voting
-------------------------------------------------------------------
10 Name of the proxy holder FMR LLC
--- ---------------------------------------- --------------------
Number of voting rights proxy holder
11 will acquire 37,147
--- ---------------------------------------- --------------------
(MORE TO FOLLOW) Dow Jones Newswires
November 10, 2015 09:43 ET (14:43 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
